Top Markets
Coin of the day
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Rankning i aktier #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Aktiekurs
$1.48
Senast synkroniserad: 2025-03-24
Marknadsvärde
$59.05M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
GB
Handel Achilles Therapeutics plc (ACHL)

Kategori

Historik för aktiesplit för Achilles Therapeutics plc (ACHL)
Aktien Achilles Therapeutics plc (symbol: ACHL) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 22, 2026.
En ACHL-aktie köpt före Aug 22, 2026 motsvarar nu 0 ACHL-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH